S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
CVE:IGX

IntelGenx Technologies (IGX) Stock Forecast, Price & News

C$0.58
+0.01 (+1.75%)
(As of 10/6/2021)
Compare
Today's Range
C$0.58
C$0.60
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.17
C$0.85
Volume
11,848 shs
Average Volume
56,279 shs
Market Capitalization
C$87.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IGX stock logo

About IntelGenx Technologies (CVE:IGX) Stock

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

IGX Stock News Headlines

8-K: IntelGenx Technologies Corp.
IntelGenx Extends Period to Exercise Certain Warrants
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
IntelGenx Technologies Corp. (IGX.TO)
IIROC Trading Halt - IGX.WT
IntelGenx Reports Third Quarter 2022 Financial Results
IntelGenx Reports Second Quarter 2022 Financial Results
Stocks in play: IntelGenx Technologies Corp.
See More Headlines
Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.75 million
Cash Flow
C$0.08 per share
Book Value
C$0.05 per share

Miscellaneous

Free Float
N/A
Market Cap
C$87.32 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Horst G. Zerbe (Age 74)
    Chairman, CEO & Chairman of Scientific Advisory Board
    Comp: $240.75k
  • Mr. André Godin C.A. (Age 57)
    CPA, CPA, CA, Pres & CFO
    Comp: $223.6k
  • Ms. Nadine Paiement (Age 44)
    Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp
    Comp: $140.13k
  • Dr. Dana Matzen (Age 43)
    VP of Bus. & Corp. Devel. of IntelGenx Corp
    Comp: $171.43k
  • Stephen Kilmer
    Investor Relations Officer
  • Dr. Rodolphe Obeid Ph.D. (Age 41)
    VP of Operations - IntelGenx Corp
  • Mr. Tommy Kenny J.D. (Age 34)
    L.L.B., M.Sc., VP of Intellectual Property & Legal Affairs and Gen. Counsel of IntelGenx Corp
  • Ms. Ingrid Zerbe (Age 67)
    Corp. Sec.













IGX Stock - Frequently Asked Questions

How have IGX shares performed in 2023?

IntelGenx Technologies' stock was trading at C$0.58 at the beginning of the year. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Aurora Cannabis (ACB), New Age Brands (NF), Capstone Copper (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group (AC8), Cameco (CCJ) and Baylin Technologies (BYL).

What is IntelGenx Technologies' stock symbol?

IntelGenx Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX."

How do I buy shares of IntelGenx Technologies?

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is IntelGenx Technologies' stock price today?

One share of IGX stock can currently be purchased for approximately C$0.58.

How much money does IntelGenx Technologies make?

IntelGenx Technologies (CVE:IGX) has a market capitalization of C$87.32 million and generates C$1.75 million in revenue each year.

How can I contact IntelGenx Technologies?

The official website for the company is www.intelgenx.com. The company can be reached via phone at 514-331-7440.

This page (CVE:IGX) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -